KNSA Annual Operating Profit
-$25.20 M
-$34.97 M-357.81%
31 December 2023
Summary:
As of January 20, 2025, KNSA annual operaing income is -$25.20 million, with the most recent change of -$34.97 million (-357.81%) on December 31, 2023. During the last 3 years, it has risen by +$132.17 million (+83.99%). KNSA annual operating profit is now -357.81% below its all-time high of $9.77 million, reached on December 31, 2022.KNSA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Quarterly Operating Profit
-$9.66 M
-$9.54 M-8154.70%
30 September 2024
Summary:
As of January 20, 2025, KNSA quarterly operating income is -$9.66 million, with the most recent change of -$9.54 million (-8154.70%) on September 30, 2024. Over the past year, it has increased by +$1.27 million (+11.61%). KNSA quarterly operating profit is now -120.81% below its all-time high of $46.41 million, reached on September 30, 2022.KNSA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA TTM Operating Profit
-$26.24 M
+$1.27 M+4.61%
30 September 2024
Summary:
As of January 20, 2025, KNSA TTM operating income is -$26.24 million, with the most recent change of +$1.27 million (+4.61%) on September 30, 2024. Over the past year, it has dropped by -$7.01 million (-36.43%). KNSA TTM operating profit is now -168.84% below its all-time high of $38.11 million, reached on June 30, 2023.KNSA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -357.8% | +11.6% | -36.4% |
| 3 y3 years | +84.0% | +68.5% | +84.9% |
| 5 y5 years | +76.7% | +68.3% | +84.6% |
KNSA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -357.8% | +83.9% | -120.8% | +73.3% | -168.8% | +83.3% |
| 5 y | 5-year | -357.8% | +85.2% | -120.8% | +81.7% | -168.8% | +85.9% |
| alltime | all time | -357.8% | +85.2% | -120.8% | +85.7% | -168.8% | +85.9% |
Kiniksa Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.66 M(+8154.7%) | -$26.24 M(-4.6%) |
| June 2024 | - | -$117.00 K(-99.3%) | -$27.50 M(-9.9%) |
| Mar 2024 | - | -$16.54 M(<-9900.0%) | -$30.54 M(+21.2%) |
| Dec 2023 | -$25.20 M(-357.8%) | $81.00 K(-100.7%) | -$25.20 M(+31.0%) |
| Sept 2023 | - | -$10.93 M(+246.4%) | -$19.23 M(-150.5%) |
| June 2023 | - | -$3.15 M(-71.8%) | $38.11 M(+74.1%) |
| Mar 2023 | - | -$11.20 M(-285.1%) | $21.90 M(+124.0%) |
| Dec 2022 | $9.77 M(-106.2%) | $6.05 M(-87.0%) | $9.77 M(-130.2%) |
| Sept 2022 | - | $46.41 M(-339.6%) | -$32.41 M(-70.4%) |
| June 2022 | - | -$19.37 M(-16.9%) | -$109.48 M(-16.2%) |
| Mar 2022 | - | -$23.32 M(-35.5%) | -$130.67 M(-16.6%) |
| Dec 2021 | -$156.64 M(-0.5%) | -$36.13 M(+17.8%) | -$156.64 M(-9.7%) |
| Sept 2021 | - | -$30.67 M(-24.4%) | -$173.40 M(-6.7%) |
| June 2021 | - | -$40.55 M(-17.7%) | -$185.95 M(+4.9%) |
| Mar 2021 | - | -$49.28 M(-6.8%) | -$177.26 M(+12.6%) |
| Dec 2020 | -$157.36 M | -$52.90 M(+22.4%) | -$157.36 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$43.22 M(+35.6%) | -$137.05 M(+10.3%) |
| June 2020 | - | -$31.86 M(+8.4%) | -$124.27 M(-5.6%) |
| Mar 2020 | - | -$29.39 M(-9.8%) | -$131.70 M(-22.5%) |
| Dec 2019 | -$169.96 M(+57.1%) | -$32.58 M(+7.0%) | -$169.96 M(-6.4%) |
| Sept 2019 | - | -$30.45 M(-22.5%) | -$181.52 M(+2.4%) |
| June 2019 | - | -$39.29 M(-41.9%) | -$177.23 M(+11.1%) |
| Mar 2019 | - | -$67.65 M(+53.3%) | -$159.47 M(+47.4%) |
| Dec 2018 | -$108.16 M(+65.4%) | -$44.13 M(+68.7%) | -$108.16 M(+11.8%) |
| Sept 2018 | - | -$26.16 M(+21.5%) | -$96.74 M(+11.4%) |
| June 2018 | - | -$21.53 M(+31.7%) | -$86.83 M(+13.2%) |
| Mar 2018 | - | -$16.34 M(-50.0%) | -$76.69 M(+17.3%) |
| Dec 2017 | -$65.40 M(+172.5%) | -$32.71 M(+101.3%) | -$65.40 M(+100.1%) |
| Sept 2017 | - | -$16.25 M(+42.6%) | -$32.69 M(+98.8%) |
| June 2017 | - | -$11.39 M(+125.7%) | -$16.44 M(+225.7%) |
| Mar 2017 | - | -$5.05 M | -$5.05 M |
| Dec 2016 | -$24.00 M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual operating profit year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly operating profit year-on-year change?
- What is Kiniksa Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM operating profit year-on-year change?
What is Kiniksa Pharmaceuticals annual operaing income?
The current annual operating profit of KNSA is -$25.20 M
What is the all time high annual operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual operaing income is $9.77 M
What is Kiniksa Pharmaceuticals annual operating profit year-on-year change?
Over the past year, KNSA annual operaing income has changed by -$34.97 M (-357.81%)
What is Kiniksa Pharmaceuticals quarterly operating income?
The current quarterly operating profit of KNSA is -$9.66 M
What is the all time high quarterly operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly operating income is $46.41 M
What is Kiniksa Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, KNSA quarterly operating income has changed by +$1.27 M (+11.61%)
What is Kiniksa Pharmaceuticals TTM operating income?
The current TTM operating profit of KNSA is -$26.24 M
What is the all time high TTM operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM operating income is $38.11 M
What is Kiniksa Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, KNSA TTM operating income has changed by -$7.01 M (-36.43%)